Methylglyoxal: possible link between hyperglycaemia and immune suppression?
- 30 September 2009
- journal article
- Published by Elsevier BV in Trends in Endocrinology & Metabolism
- Vol. 20 (7), 312-317
- https://doi.org/10.1016/j.tem.2009.03.010
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Advanced Glycation End Products of DNA: Quantification of N2-(1-Carboxyethyl)-2′-deoxyguanosine in Biological Samples by Liquid Chromatography Electrospray Ionization Tandem Mass SpectrometryChemical Research in Toxicology, 2008
- Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucoseClinical and Experimental Immunology, 2008
- Receptor for Advanced Glycation End ProductsAnnals of the New York Academy of Sciences, 2008
- The tandem of free radicals and methylglyoxalChemico-Biological Interactions, 2008
- Dynamic changes in CD4+ CD25+ high T cell apoptosis after the diagnosis of type 1 diabetesClinical and Experimental Immunology, 2007
- Diabetes associated cell stress and dysfunction: role of mitochondrial and non‐mitochondrial ROS production and activityJournal Of Physiology-London, 2007
- Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor‐β: implications for diabetic atherosclerosisThe FASEB Journal, 2007
- Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiolsBiochemical Journal, 2006
- Diabetes‐induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytesImmunology, 2006
- NK Cells and Type 1 DiabetesJournal of Immunology Research, 2006